Grantham, Mayo, Van Otterloo & Co (GMO)
SYNA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Synaptics SYNA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio SYNA Stock Details SYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,800
Closed -$270K – 933
2020
Q4 		$270K Sell
2,800
-700
-20% -$57K ﹤0.01% 762
2020
Q3 		$281K Buy
+3,500
New +$277K ﹤0.01% 699
2014
Q4 		– Sell
-26,519
Closed -$1.94M – 469
2014
Q3 		$1.94M Buy
+26,519
New +$2.16M 0.01% 353
2014
Q2 		– Sell
-75,900
Closed -$4.56M – 550
2014
Q1 		$4.56M Buy
+75,900
New +$4.51M 0.01% 311

Other funds holding SYNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s SYNA Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Synaptics (SYNA) in Q1 2021, closing a stake of 2,800 shares — an estimated $270K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SYNA in Q1 2014 and held it in 4 quarters. The position peaked at $4.56M in Q1 2014. 296 funds tracked by Wall St. Rank hold SYNA as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Synaptics position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,800 Synaptics shares in Q1 2021, an estimated $270K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Synaptics in Q1 2014 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Synaptics position peaked at $4.56M in Q1 2014.
  • 296 funds tracked by Wall St. Rank held Synaptics as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.